Filing Flows › 8-K events › Terawulf
Terawulf: entry into a material definitive agreement
Form 8-K filed Oct 23, 2026 · items 1.01, 2.03
What the filing says
On October 23, 2026 (the “Effective Date”), TeraWulf Inc. (“TeraWulf” or the “Company”) entered into Amendment No. 1 (the “Amendment”) to the Existing Credit Agreement (as defined below), by and among the Company, as borrower, certain of the Company’s subsidiaries, as guarantors, the lenders from time to time party the
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 2.03: 0.0% next session across 13,268. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.
Terawulf at a glance
Terawulf, Q3 2026: revenue $76.2M (+51% year over year), operating margin -115.7%. The chart follows the revenue to costs, profit and cash.
Terawulf: every quarter, Q/Q and Y/Y, holders and guidance →
Terawulf’s other material 8-Ks
- Nov 6, 2026 — Mergers and acquisitions TeraWulf Reports Third Quarter 2026 Results
- Nov 4, 2026 — Entry into a material definitive agreement TeraWulf Secures Google Credit Backstop for Project Financing in Support of $19 Billion Anthropic Le
Other recent debt and financing
- Airsculpt Technologies Nov 6, 2026
- Starry Sea Acquisition Nov 6, 2026
- Repligen Nov 6, 2026
- Evertec Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Reed's Nov 6, 2026
- Protagenic Therapeutics, Inc.\new Nov 6, 2026
- CNL Strategic Residential Credit Nov 6, 2026
- Health In Tech Nov 6, 2026
- Profusa Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.